CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer
Authors
Ajay Bapna
Alberti
+33Â more
American Cancer Society
Annantbhushan A. Ranade
Artym
Atul Varadhachary
de la Rosa
Dial
Dinesh C. Doval
Ganapathi Raman
Hayashida
Hayashida
Hayes
Hayes
Jayaprakash Madhavan
Jonasch
Legrand
Parikh
Parikh
Pramod K. Julka
Purvish M. Parikh
Raghunadharao Digumarti
Rajesh Malik
Shekhar Patil
Shona Nag
Spadaro
Spadaro
Sun
Suresh H. Advani
Therasse
Troost
Varadhachary
Ward
Wolf
Yenyun Wang
Publication date
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1097%2Fjto.0b013e3...
Last time updated on 01/04/2019